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Abstract
Ticks act as vectors for a number of different pathogens such as Borrelia burgdorferi the
causative agent of Lyme disease. The most prominent tick vector in the United States is
the deer tick Ixodes scapularis. Tick bites are of special public health concern since there
are no vaccines available against most tick transmitted pathogens. Based on the
observation that host animals such as guinea pigs or humans can develop adaptive
immune responses to tick bites, anti-tick vaccination is a potential approach to mitigate
health risks associated with tick bites.
The study presented here aimed at identifying immunogenic salivary proteins from
I. scapularis recognized by human immune sera. To identify these potential antigens,
which later on need to be characterized with regards to their vaccination potential, a phage
display approach was utilized. Antigen libraries derived from salivary gland mRNA of 18 h
fed I. scapularis were screened with human immune sera.
Screening with an antigen library derived from nymphal ticks led to identification of a
metalloprotease. This enzyme has been described previously and appears promising as a
novel vaccine candidate. Furthermore, it has close homologs in other ixodid species
raising its potential as a universal vaccine.
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1 Introduction
1.1 Ticks act as vectors for a number of disease causing agents
Pathogen transmission by ticks is a worldwide problem that causes significant health risks
and economic losses (Wikel and Alarcon-Chaidez, 2001). The hard tick Ixodes scapularis,
which is prevalent in the United States especially in the north east, functions as a vector
for a number of pathogens such as the Lyme disease spirochete Borrelia burgdorferi, as
well as the agents of human anaplasmosis (Anaplasma phagocytophilum) (Dai et al.,
2010), human babesiosis (Babesia microti) and selected flaviviruses (Schuijt et al., 2011b)
such as an encephalitits causing virus (Turtle et al., 2012) amongst other examples. There
are currently no vaccines available for most of these tick-transmitted infections frustrating
prevention of health risks posed by tick-bites.
Ticks are obligate ectoparasites that require blood meals which can be taken from a vast
array of different hosts such as mammals, birds or even reptiles (Francischetti et al.,
2009). Furthermore, the blood meal is essential for the tick with respect to life cycle
progression. Ticks traverse through three different life cycle stages starting as larvae that
hatch from eggs. After acquisition of their first blood meal, most commonly on small rodent
hosts, the larvae overwinter and finally molt into nymphs. Nymphs require another blood
meal before molting into adults (Brunner et al., 2011). Adult female Ixodes scapularis ticks
take one last blood meal which is essential before oviposition and eventually die after the
eggs have been laid (Francischetti et al., 2009).
Interestingly, the rates of transovarian pathogen transmission from the adult tick to the
eggs/larvae are very low, at least with regards to bacterial pathogens. Thus, larvae
become infected when obtaining their first blood meal on a host that already carries the
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pathogen (Brunner et al., 2011; Mather et al., 1989). Consequently, nymphal ticks receive
a high significance when considering pathogen transmission to humans.
Pathogen transmission can be classified as a bidirectional process in which tick feeding on
a host is required, defining the tick as a vector for the respective pathogen. Additionally,
the phenomenon of infection among co-feeding ticks has been observed in which the
pathogen transfers from the infected tick to a non-infected tick feeding in close proximity
(Jones et al., 1989). Many different studies outline the central role tick saliva plays in
efficient feeding as well as pathogen transmission, strengthening the interest in saliva in
vector biology. Also, the way in which the pathogen is sustained and keeps spreading
becomes obvious as it utilizes the tick as a carrier to get from one host to another. In the
case of B. burgdorferi, transmission via ticks is the only known mechanism by which
humans become infected (Tilly et al., 2008).

1.2 Saliva plays a central role in successful tick feeding
Saliva plays a central role in tick-feeding and has been shown to have anti-hemostatic and
anti-inflammatory effects as well as immuno-modulatory properties which impair the host’s
innate and adaptive immune system. Saliva constitutes a highly complex pharmacological
cocktail which contains numerous bioactive lipids and proteins that also act in redundant
ways (Brossard and Wikel, 2004; Carvalho et al., 2010). Brossard and Wikel (2004)
provide a very detailed description of tick saliva compounds and their actions in tick
feeding. Amongst other examples they describe IL-8 binding proteins that inhibit binding of
IL-8 to its receptor, prostaglandins that shift the expression pattern of cytokines towards a
Th2 response, inhibitors of T cell activation like Salp15 or immunoglobulin binding proteins
that prevent effector functions.
Strengthening the importance of tick saliva in tick-borne disease transmission, studies
have shown that pathogen transmission using its natural vector is more efficient than
2

artificial injections with a needle and syringe underlining the fact that saliva actively
benefits pathogen transmission (Frischknecht, 2007). Additionally, pathogen transmission
from the host to the tick is promoted by tick salivary proteins like the glutathione
peroxidase Salp25D. Knock-down experiments for this protein have shown a decreased
transmission of B. burgdorferi from infected hosts to the tick vector (Narasimhan et al.,
2007b). Furthermore, immunization of mice with recombinant Salp25D impaired pathogen
transmission from the tick to the host (Das et al., 2001).
A recent study using yeast-surface display identified five immunogenic salivary proteins
from fully engorged I. scapularis nymphs capable of immunizing rabbits when given as a
cocktail (Schuijt et al., 2011b). Results obtained by the same group revealed the
importance of another salivary protein, tick histamine-release factor (tHRF), during late
phases of the feeding process. When the tHRF gene was silenced by RNA interference,
tick blood feeding success was impaired significantly (Dai et al., 2010). Since histamine is
a pro-inflammatory cytokine, the effect achieved by tHRF seems to be counterintuitive.
However, this finding leads to another important property of the salivary proteins: gene
expression in the salivary glands during feeding is highly dynamic and adapts to the tick’s
current requirements (McNally et al., 2012; Narasimhan et al., 2007a). This also leads to
the necessity of clearly defining feeding time-points in studies of the feeding process and
salivary gland expression dynamics (Ribeiro et al., 2006; Valenzuela et al., 2002). The
dynamics of gene expression in the salivary glands also are represented by the fact that
the feeding process can be divided into a total of nine different phases including host
seeking, several different feeding stages as well as detachment (Anderson and Magnarelli,
2008). Of special interest are the early phases of feeding in which the tick has to establish
its bite site. It has been stated that in the first 24 h of the feeding process (which can last
up to one week) only minute amounts of blood are taken up by the tick and that little to no
pathogen transmission occurs (Dai et al., 2010).
3

1.3 Acquired tick-bite immunity
Given that there are more than 20,000 new infections just of B. burgdorferi solely in the
United States every year (Marques, 2010), the threat that ticks pose to human and animal
health becomes abundantly clear. Nevertheless, the tick faces an impressive array of host
defense mechanisms which need to be overcome in order to successfully obtain a blood
meal (Brossard and Wikel, 2004; Francischetti et al., 2009). In addition to innate
mechanisms like hemostasis or inflammation (Francischetti et al., 2008) many hosts have
been shown to acquire specific tick-bite immunity (Ribeiro, 1995).
The first scientific report of acquired immunity against ticks in guinea pigs was published
over 70 years ago (Trager, 1939). This report describes that upon repeated infestation with
the dog tick, Dermacentor variabilis, guinea pigs developed inflammatory reactions leading
to impaired tick feeding and increased tick mortality rates (Trager, 1939). Similar results
using other tick species and hosts such as rabbits or bovines have confirmed those early
findings (Kashino et al., 2005; Wikel, 1996; Willadsen and Jongejan, 1999).
Acquired tick immunity can manifest itself in many different ways. Among the valid
definitions listed in the literature are decreased numbers of ticks engorging on a host or
decreased weight of the ticks, as well as prolonged feeding, premature drop-off,
decreased oviposition or even death of the tick as well as hypersensitivity reactions of the
host (Wikel, 1996; Willadsen and Jongejan, 1999).
Studies in mice have revealed critical components of the innate and adaptive immune
system with respect to acquired tick bite immunity. A study focusing on basophils and mast
cells as well as different Ig receptors on their surface showed that these cell types as well
as immunoglobulins of the IgG and the IgE class are essential for acquired tick immunity
(Wada et al., 2010).
Immunization studies using bovines have confirmed the importance of immunoglobulins of
the IgG class (Kashino et al., 2005). IgE antibodies have also repeatedly been reported as
4

central players in tick-bite hypersensitivity, making them exciting probes for immunogenic
salivary protein discovery (Brossard and Wikel, 2004; Matsuda et al., 1990).
Furthermore, acquired tick immunity has also been related to impaired pathogen
transmission (Nazario et al., 1998; Wikel et al., 1997) leading to a simple but genuine idea:
Preventing successful tick feeding on a host may prevent pathogen transmission.

1.4 Vaccination against ticks
The finding that acquired tick-bite immunity also affects pathogen transmission led to the
idea of anti-tick vaccination. To date, there is only one commercially available anti-tick
vaccine which is used in cattle and based on the midgut protein Bm86 from the cattle tick
Boophilus microplus (de la Fuente et al., 2007a; de la Fuente et al., 2007b). For humans,
there are currently no vaccines available against most of the pathogens transmitted by
ticks. An efficient vaccine against tick vectors, however, would not only lower the
vaccination burden for patients but also protect against a larger array of tick-borne
diseases. Furthermore, it could provide an opportunity to decrease the application of
acaricides which will have beneficial effects on the environment and agriculture. Also
compromising the use of acaricides is the fact that some species of ticks have been
observed to quickly develop resistance (Willadsen, 2004). The quest to identify
immunogenic antigens that reveal a high efficacy in vaccination has proven difficult.
Willadsen (2004) listed three different approaches that have been utilized to identify such
potential antigens. First, he names the use of blood sera from tick immune animals as
probes. A second approach is presented by analyses of proteins that are essential to the
tick’s function and third, biochemical fractionation can be used to determine the minimal
protein mixture that elicits a protective response when given as a vaccine (Willadsen,
2004).
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Salivary proteins appear to be of special interest when it comes to identifying vaccine
candidates and there are a number of different reports that have successfully identified
immunogenic salivary proteins (Das et al., 2001; Schuijt et al., 2011a; Schuijt et al.,
2011b). It has been suggested that targeting salivary proteins of the early feeding phase (<
24 h), in which it is also known that almost no pathogen transfer occurs, is sufficient to
establish a sound immune response (Narasimhan et al., 2007a). However, limiting the
search of novel vaccine candidates to salivary glands might appear somewhat
shortsighted, since as it was stated above, the only commercially available vaccine is
based on a midgut protein, revealing the importance of such concealed antigens (Nuttall et
al., 2006). Host antibodies appear capable of traversing the host-tick interface where they
can bind their respective antigens, for example in the tick’s gut, leading to damage of the
tick after it has engorged on blood (Willadsen, 2004). Salivary protein antigens represent
an excellent potential target for disrupting tick feeding and in particular, the pathogen
transmission and infection process should pathogens reach host tissue.
Besides immunogenicity, cross-species reactivity would be another desirable trait for an
identified vaccine candidate. With more than 900 different tick species identified to date, a
vaccine that protects against multiple species would be highly advantageous. In
accordance with this notion it can be stated that there are a significant number of
homologous proteins described between different species, a finding that confirms hopes
for effective cross-species vaccines (Parizi et al., 2012).
Finally, it has to be noted that tick-host interactions are typically specific, and that findings
in one tick/host system cannot be extended to others without appropriate experimentation
(Lawrie and Nuttall, 2001; Willadsen and Jongejan, 1999). This statement illustrates the
highly complex interactions and reactions to different stimuli and also further complicates
the identification of vaccine candidates, especially if laboratory animals are used to identify
vaccines for future use in humans.
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1.5 Phage Display
Phage display is a robust technique suited for high-throughput screenings of specific and
high-affinity interactions between biomolecules, especially proteins and peptides such as
antibody fragments and/or antigens (Schirrmann et al., 2011). The technique was
developed in the mid 1980s by George P. Smith (Smith, 1985). Since then, many
improvements and modifications have been introduced such that phage display has
become one of the most important affinity screening methods.
The major strength of the system is established by the intrinsic connection of genotype
and phenotype. This connection becomes clear after briefly considering the biology of
filamentous phage which are primarily used for displaying proteins (Sidhu, 2005).
Filamentous phage can be grouped into different strains such as M13, fd or f1. They are
comprised of an outer protein capsid consisting primarily of the major coat protein pVIII
which is responsible for up to 87% of the phages’ mass (Smith and Petrenko, 1997). The
tips of the 1 µm long, rod shaped phage are built up by the minor coat proteins pIII and pXI
on one end and pVII and pIX on the other end. Inside the phage particle, the ssDNA
encoding all phage proteins is located. Filamentous phage infect their host E. coli via the F
pilus present on the surface of the bacterial cell. pIII is essential for infection as its Nterminus initiates the contact to the F pilus, eventually translocating the viral ssDNA into
the cytoplasm. Here, the complementary DNA strand is synthesized by host enzymes to
yield the replicative form, from which phage proteins are expressed. Finally, new phage
particles are assembled and leave the host cell via a non-lytic mechanism (Barbas, 2001).
Phage particles can now be utilized to display foreign proteins on their surface by fusion of
the respective gene to the gene encoding one of the surface proteins, preferably pIII
(Georgieva and Konthur, 2011). The result is a peptide::pIII fusion protein whose genetic
information is directly encoded by the DNA located inside the phage particle. Thus, the
connection of genotype and phenotype is achieved (Hust et al., 2006). The feature of
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foreign peptides such as antibody fragments or potential antigens displayed on the phage
surface permits efficient screening for interactions of these peptides with other molecules
of interest. Such a screening is called biopanning (Konthur and Crameri, 2003).
There are different strategies available for fusion of the gene of interest with the gene
encoding the coat protein. Fusion directly within the phage genome is one opportunity, or
use of specialized plasmids, called phagemids, which carry the respective coat protein
gene and regulatory elements, can be utilized (Qi et al., 2012).
Phage Display has been shown previously to be highly efficient with respect to screening
large libraries containing antibody fragments and identifying binders to many different
antigens (Colwill and Graslund, 2011; Hust et al., 2011). Conversely, the same
methodology can be used to construct antigen libraries to identify potentially immunogenic
proteins from various organisms (Kugler et al., 2008; Meyer et al., 2012; Naseem et al.,
2010). One major disadvantage of cDNA or gDNA expression libraries are non-functional
inserts that are cloned in the wrong orientation, are not in frame with the gIII gene or
leader peptide, or contain stop codons or parts of the untranslated regions (Georgieva and
Konthur, 2011).
An elegant way to tackle this issue is the introduction of a phagemid/helperphage system
in which the helperphage (called Hyperphage) lacks a functional gIII (Rondot et al., 2001).
In this case, the only functional pIII, which is essential for phage packaging, results from
the phagemid and thus requires in-frame cloning of an insert that does not contain a stop
codon. In the process of phage packaging these constructs are directly selected, leading
to an enrichment of open reading frames (ORFs). Accordingly, the pHORF/Hyperphage
system that has been published previously (Hust et al., 2006; Kugler et al., 2008; Meyer et
al., 2012) was utilized in the study presented here. Figure 1-1 illustrates the whole process
of library construction, packaging including ORF enrichment, biopanning and subsequent
screening for immunogenic peptides.
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Figure 1-1: Illustration of the construction of an antigen phage display library with subsequent packaging and
ORF enrichment (top panel). After packaging of the library into phage particles a biopanning is performed
using immobilized capture antibody and immune sera to enrich phage particles displaying immunogenic
peptides. After three rounds of affinity enrichment a screening ELISA is performed to identify those phages
displaying immunogenic peptides. Adapted from Meyer et al., 2012
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1.6 Goal of the study
The goal of this master thesis research was to identify immunogenic proteins from the
salivary glands of the deer tick, Ixodes scapularis. The criterion applied to classify a
protein as immunogenic was its recognition by antibodies from human blood sera. Human
subjects contributing blood sera were previously known to have strong immune responses
to tick bites.
To identify these salivary proteins, a phage display approach based on an antigen library
constructed from mRNA of ticks, fed for 18 hours on a rodent host, was used. This antigen
library was packaged into phage particles and screened against the human sera available
as illustrated in Figure 1-1.
Proteins selected in this analysis are predicted to function as novel vaccine candidates
with special emphasis to application in humans.
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2 Materials and Methods
2.1 Equipment
For the research carried out in this study the following equipment and devices were used.
Table 2-1: Equipment used in this study

Apparatus
Blotting Machine
Centrifuges

Cleanbenches

Electrophoresis chamber

ELISA Reader
ELISA Washer
Gel Documentation
Incubators

Model
Trans-Blot Turbo
5415 D
5819 R
Sorval RC6 Plus
Multifuge 3 S-R
Hera safe
MSCAdvantage

Manufacturer
Bio-Rad, Munich
Eppendorf, Hamburg
Eppendorf, Hamburg
Kendro, Langenselbold
Heraeus, Hanau
Heraeus, Hanau
Thermo Fisher Scientific,
Bonn

Biotechnology Model 400708
Mini Protean III for SDS
PAGE
Sunrise
Columbus Pro
Get Jet Imager
BE 400
Certomat BS-1

Peqlab, Erlangen

Infors HT (shaking
incubator)
I-series 24
6251
Pipettes
Power Supplies

Rocker
Rotating Shaker
Scales
Thermocycler
Thermomixer

Research
Electrophoresis Power
Supply 301
Electrophoresis Power
Supply 601
GFL 3013
Rotator RS-24
Analytic 1205MP
Fine scale laboratory
S1000 Thermal Cycler
Mastercycler 621
Compact
Comfort
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Bio-Rad, Munich
Tecan, Crailsheim
Tecan, Crailsheim
Intas, Göttingen
Memmert, Schwabach
B. Braun Biotech,
Melsungen
Infors, Einsbach
New Brunswick Scientific,
Enfield, CT
Thermo Scientific, Asheville,
NC
Eppendorf, Hamburg
Amersham Bioscience,
Freiburg
Omnilab Laborzentrum,
Bremen
Kisker Biotech, Steinfurt
Sartorius, Göttingen
Bio-Rad, München
Eppendorf, Hauppauge, NY,
USA
Eppendorf, Hamburg
Eppendorf, Hamburg

Tissue Lyser

Tissue Lyser II

Qiagen, Valencia, CA, USA

Ultrasound Sonicator

Sonoplus
Sonicator 3000

Vortex
Water Installation

REAX2000
Arium 611

Bandelin
Misonix, Farmingdale, NY,
USA
Heidolph, Schwabach
Sartorius, Göttingen

2.2 Consumable Supplies
Consumable supplies utilized in this study are listed in the following table.
Table 2-2: Consumable supplies used in this study

Material
Dynabeads M270 Carboxylic Acid
Disposable Cuvettes
Electroporation cuvettes 1 mm
Inoculation loops
MTP 96 Well Flat Bottom
MTP 96 Well Polypropylene, U-shaped
MTP 96 Well Polystyrole, High Binding
MTP cover foil AeraSeal
MTP cover foil Sealplate
PCR stripes
Petri dishes (7 cm, 15 cm)
Petri dishes, squared (24.5 cm)
Pipette tips
Pipette tips, filtered
PVDF membrane
Reaction tube (1.5 ml, 2 ml)
Reaction tube (15 ml, 50 ml)
Screw-top micro caps
Spatulas
Sterile filter (0.2 µm, 0.45 µm)

Manufacturer
Invitrogen Dynal AS, Oslo, Norway
Brand, Wertheim
Bio-Rad, Munich
VWR, Darmstadt
Sarstedt, Nümbrecht
Greiner-Bio-one, Frickenhausen
Costar, USA
Excel Scientific, Victorville, CA, USA
Greiner-Bio-one, Frickenhausen
Greiner-Bio-one, Frickenhausen
Sigma, Munich
Sarstedt, Nümbrecht
Greiner-Bio-one, Frickenhausen
Carl Roth, Karlsruhe
Sarstedt, Nümbrecht
Greiner-Bio-one, Frickenhausen
Sarstedt, Nümbrecht
VWR, Darmstadt
Sartorius, Göttingen

2.3 Kits and Markers
The following kits were used for isolation and purification of nucleic acids.
Table 2-3: Kits used in this study

Kit
Illustra mRNA purification Kit
NucleoSpin Gel and PCR Clean-up
peqGOLD MINIprep Kit I
PlusOne Silver Staining Kit protein
RNeasy MiniElute Clean-up Kit

Manufacturer
GE Healthcare, Piscataway, NJ, USA
Macherey-Nagel, Düren
Peqlab, Erlangen
GE Healthcare, Piscataway, NJ, USA
Qiagen, Valencia, CA, USA
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Markers used in gel electrophoretic analyses (DNA and protein) are listed in the following
table.
Table 2-4: DNA and protein markers used in this study

DNA Marker
GeneRuler 1 kb Plus Ladder
100 bp DNA ladder
Protein Marker
Precision Plus Protein dual color
Precision Plus Protein unstained

Fermentas, St. Leon-Rot
NEB, Frankfurt a. M.
Bio-Rad, Munich
Bio-Rad, Munich

2.4 Chemicals
Unless noted differently, all chemicals were obtained from the following companies:
Sigma-Aldrich Chemie GmbH, Fermentas GmbH, Merck KGaA, Riedel-de HaenHoneywell Specialty Chemicals Seelze GmbH, Roche Diagnostics GmbH, Carl Roth
GmbH & Co.KG. Media supplements were obtained from Difco-Voigt Global Distribution
Inc.
For all solutions, media and buffers prepared, cleaned and completely desalted water was
used (Arium 611, Sartorius AG).

2.5 Enzymes
Enzymes used in this study are listed in the following table.
Table 2-5: Enzymes used in this study

Enzyme
AfeI
Alkaline Phosphatase (CIP)
AluI
CviKI-1
E. coli DNA Ligase
E. coli DNA Polymerase I
ExTaq DNA Polymerase
GoTaq DNA Polymerase
Large Klenow Fragment
MMLV Reverse Transcriptase
PmeI

Manufacturer
NEB, Frankfurt a. M.
NEB, Frankfurt a. M.
NEB, Frankfurt a. M.
NEB, Frankfurt a. M.
NEB, Frankfurt a. M.
NEB, Frankfurt a. M.
Takara
Sigma, Munich
NEB, Frankfurt a. M.
NEB, Frankfurt a. M.
NEB, Frankfurt a. M.
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RNAse H
Superscript II Reverse Transcriptase
T4 DNA Polymerase
T4 Ligase
Trypsin

Invitrogen
Invitrogen
NEB, Frankfurt a. M.
Promega
Sigma, Munich

2.6 Antibodies
Antibodies used in this study are listed in the following table. Dilutions were always
prepared in 2% MPBST unless noted otherwise.
Table 2-6: Antibodies used in this study

Antibody
Mouse α-M13 IgG (fd, F1),
monoclonal
Mouse α-human IgG (Fc specific),
monoclonal
Goat α-human IgG (Fc specific)Peroxidase conjugated, polyclonal
Mouse α-M13-Peroxidase
conjugated, monoclonal
Goat α-human IgG polyvalent
Goat α-human IgG (Fc specific)
phosphatase conjugated

Dilution

Manufacturer
Progen, Heidelberg

1:1000

Sigma, Munich

1:5000
1:70000
1:40000

Sigma, Munich
GE Healthcare
Sigma, Munich

1:6700

Dianova, Hamburg

1:5000
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2.7 Bacteria, Bacteriophages and Plasmids
Bacterial strains as well as bacteriophages used in this study are listed in the following
table.
Table 2-7: Bacteria and helperphages used in this study

Bacterial Strain
E. coli XL1-Blue-MRF’

Genotype
K12: Δ(mcrA)183 Δ(mcrCBhsdSMR-mrr)173 endA1
supE44 thi-1 recA1 gyrA96
relA1 lac [F‘ proAB lacIqZ
ΔM15 Tn10 (TetR)

Source
Stratagene

E. coli Top10F’

K12: F- mcrA Δ(mrrhsdRMS-mcrBC)
φ80lacZΔM15 ΔlacX74
nupG recA1 araD139 Δ(araleu)7697 galE15 galK16
rpsL(StrR) endA1 λ-

Invitrogen

E. coli DH5α 409-1 (K02)
Helperphage Hyperphage

Rondot et al., 2001
AG Dübel, TU
Braunschweig

Plasmids used in this study are listed in the following table.
Table 2-8: Plasmids used in this study

Plasmid
pHORF3

Description
Phagemid vector, Cloning of
antigen-libraries, PhageDisplay, PmeI restriction site

Source
AG Dübel, TU
Braunschweig

2.8 Ticks
2.8.1

Housing

Pathogen-free Ixodes scapularis nymphs were reared using standard methods (Mather
and Mather, 1990). All unfed nymphs were generated from larvae derived from fieldcollected adult females blood fed in the laboratory. Larvae were blood fed on pathogen-
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free hamsters, collected and allowed to molt under environmental conditions of 23°C,
>90% relative humidity, and a 14 h light/10 h dark photoperiod.
Adult female Ixodes scapularis used in this study were field collected and housed under
environmental conditions of 23°C, >90% relative humidity, and a 14 h light/10 h dark
photoperiod.

2.8.2

Feeding

In all feeding experiments performed in this study, ticks were allowed to feed on a rodent
host (mouse or hamster) for 18 hours. After 18 hours ticks were pulled off the host and
stored in a glass vial with a wet paper towel until subsequent dissection. All animal studies
were performed in accordance with protocols AN04-10-006 and AN08-04-017 under the
University of Rhode Island, Institutional Animal Care and Use Committee (IACUC).

2.8.3

Dissections

For dissections, fed ticks were immobilized on a glass slide previously prepared with
double sided sticky tape. 15 µl of PBS were placed on the tick and the animal was opened
using a razor blade. Salivary glands were dissected using fine needles and transferred
either into ice cold PBS or mRNA Extraction buffer at room temperature depending on the
experiment.

2.8.4

Preparation of salivary gland homogenate (SGH)

Salivary glands dissected previously and stored in PBS (see section 2.8.3) were placed on
ice. Samples were sonicated three times for 20 s using the Sonicator 3000 at an intensity
of 5.0. Between each sonication step the sample was centrifuged at 10,000 x g and 4°C
for 2 min. After the third sonicaion step the samples were centrifuged for 10 min and all
resulting supernatants were pooled. This pool was centrifuged again for 10 min at 10,000 x
g and 4°C and the resulting supernatant was stored at -80°C.
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2.9 Media
2.9.1

Culture media for Escherichia coli

Unless noted otherwise, E. coli were cultured in fully buffered two times yeast-tryptone
media (2xYT). For solid media 15 g agar per liter were added.
Table 2-9: Recipe for 2xYT medium

2xYT Medium
Bacto-Yeast Extract
Bact-Tryptone
NaCl

1.0 % (w/v)
1.6 % (w/v)
0.5 % (w/v)

Table 2-10: Recipe for SOC medium

SOC Medium
Bacto-Yeast Extract
Bact-Tryptone
NaCl
Glucose

2.9.2

0.5 % (w/v)
2.0 % (w/v)
0.05 % (w/v)
1.8 % (w/v)

Media Supplements

Media supplements were prepared as concentrated stock solutions and autoclaved or filter
sterilized. Addition of supplements to the media was performed under sterile conditions.
For solid media supplements were added after media had reached a temperature below
55°C.
Table 2-11: Media supplements used in this study

Supplement
Ampicillin
Kanamycin
Tetracycline
Glucose
IPTG

Stock solution
100 mg/ml
50 mg/ml
10 mg/ml
2 M
1 M

Final concentration
100 µg/ml
50 µg/ml
20 µg/ml
100 mM
0.5 mM
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2.10 Buffers and Solutions
For all solutions and buffers prepared, cleaned and completely desalted water was used
(Arium 611, Sartorius AG). Concentrations listed are in water unless noted otherwise.
Table 2-12: Buffers and solution used in this study

Acrylamide Mix
Acrylamide
Bisacrylamide
Agarose Gel
Agarose
Ammonium Peroxosulphate (APS-) Solution
APS
Blotting Buffer
Tris
Glycine
Carbonate Buffer
NaHCO3, pH 9.6
ELISA Blocking Buffer
Milk powder
ELISA Washing Buffer
Tween20
Ethidium Bromide Solution
Ethidium Bromide
Laemmli Buffer (5x)
SDS
Glycerol
Bromophenol Blue
β-Mercaptoethanol
MPBS-T
Milk Powder
PBS
NaCl
KCl
Na2HPO4 x 2 H2O
KH2HPO4
PBS-T
Tween20
PEG/NaCl
PEG 6000
NaCl
Phage Dilution Buffer
Tris
NaCl
EDTA
Stacking Gel Buffer (for SDS Gel)
Tris-HCl, pH 6.8
SDS-PAGE Running Buffer
Tris

30 %
0.8 %

(w/v)
(w/v)

1.0 %

(w/v)

10 %

(w/v)

in TAE Buffer

25 mM
192 mM
50 mM
2 %

(w/v)

in PBS

0.05 %

(w/v)

in PBS

0.1 %

(w/v)

10
50
0.02
15

%
%
%
%

(w/v)
(w/v)
(w/v)
(v/v)

2 %

(w/v)

0.8
0.02
0.144
0.024

%
%
%
%

(w/v)
(w/v)
(w/v)
(w/v)

0.05 %

(v/v)

20 %
2.5 M

(w/v)

10 mM
20 mM
2 mM
1.0 M
25 mM
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in PBS-T

in PBS

Glycine
SDS
SDS Solution
SDS
TAE Buffer
Tris-HCl
Acetic acid
EDTA
TMB Reagent
Solution A, pH 4.1
Potassium Citrate
Citric acid
Solution B
Tetramethylbenzidine
Acetone
Ethanol
Hydrogen peroxide
Separating Gel Buffer (for SDS Gel)
Tris
Western Blot Substrate Buffer
Tris HCl
MgCl2

192 mM
0.1 %

(w/v)

10 %

(w/v)

4 mM
2 mM
1 mM
30 mM
0.5 M
10
10
90
0.3

mM
%
%
%

(v/v)
(v/v)
(v/v)

1.5 M
100 mM
0.5 mM

2.11 Oligonucleotides
Primers used for PCR and reverse transcription experiments are listed in the following
table.
Table 2-13: Oligonucleotides used in this study

Primer Name
MHLacZPro_f
MHgIII_r
Random Hexamers
3’ SMART CDS Primer II A
SMART II A Oligonucleotide
5’ PCR Primer II A

Sequence 5’ à 3’
GGCTCGTATGTTGTGTGG
CTAAAGTTTTGTCGTCTTTCC
Obtained from Invitrogen
AAGCAGTGGTATCAACGCAGAGTACT(30)AT
AAGCAGTGGTATCAACGCAGAGTACGCGGG
AAGCAGTGGTATCAACGCAGAGT
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2.12 Software and Databases
Software and Databases used in this study are listed in the following table.
Table 2-14: Software used in this study

Software
ExPASy Prot Scale
Geneious
MultAlin Interface
NCBI

Application
Online Tool to generate protein hydrophobicity plots
http://web.expasy.org/protscale/
Vector Management, Sequence analysis, virtual cloning
Online Sequence alignment tool
http://multalin.toulouse.inra.fr/multalin/
Literature research, sequence comparisons (BLAST),
gene and protein sequence information
http://www.ncbi.nlm.nih.gov/

2.13 Microbiological Methods
2.13.1 Liquid and solid culture media
All media were sterilized by autoclaving (121°C, 20 min, excess pressure 1 bar). Heat
sensitive supplements were filter sterilized (pore size 0.2 µm) and added to the media
under sterile conditions. For solid media Agar-Agar (Bacto) was added before autoclaving.

2.13.2 Culture Techniques
2.13.2.1 Plating
After transformation or transduction of E. coli, cell suspension was plated on a 2xYT Agar
plate supplemented with 0.1 M glucose and the respective antibiotic with a spatula.
Incubation was performed at 37°C overnight. Plates were stored at 4°C for up to four
weeks after sealing with Parafilm.

2.13.2.2 Liquid cultures
Starter cultures were prepared in 5 ml or 30 ml scale in 2xYT media supplemented with
0.1 M glucose and the respective antibiotic. Inoculation was performed either from a single
colony taken from a plate or directly from a glycerol stock. Cultures were incubated at
37°C and 250 rpm for 16 to 18 hours in a shaking incubator.
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Main cultures of volumes between 50 and 400 ml were inoculated from the starter culture
with OD600 adjusted to 0.05 to 0.09. Composition of the medium was generally set up as
for the starter culture. Incubation of the main culture was performed at 37°C and 250 rpm
in a shaking incubator until OD600 of 0.5 was reached.

2.13.3 Preparation and transformation of E. coli TOP10F’ electrocompetent cells
2.13.3.1 Preparation
1200 ml 2xYT medium were inoculated with 20 ml of an E. coli TOP10F’ starter culture to
reach an OD600 = 0.06 and incubated at 37°C and 250 rpm until an OD600 of 0.5 was
reached. Next, the culture was incubated on ice for 30 min followed by a centrifugation
step at 4000 x g, 4°C for 15 min. The cell pellets were resuspended in 800 ml ice-cold
dH2O followed by another centrifugation step at 4000 x g, 4°C for 20 min. This wash step
was repeated once. Following, the cell pellets were resuspended in 200 ml ice-cold 10%
glycerol and centrifuged at 3220 x g, 4°C for 10 min in 50 ml reaction tubes. Resuspension
of the cell pellets was performed in 1.6 ml ice-cold 10% glycerol and aliquots of 200 µl
were stored at -80°C until use.

2.13.3.2 Transformation
Prior to electroporation the electrocompetent E. coli TOP10F’ cells were thawed on ice.
DNA derived from a ligation was added to 50 µl electrocompetent cells and incubated on
ice for 5 min. Subsequently the DNA-cell suspension was filled into pre-chilled cuvettes
and electroporation was performed with a pulse of 1.7kV. 1 ml SOC medium with a
temperature of 37°C was added immediately and the cells were incubated at 37°C and
600 rpm for 1 h. Finally the whole cell suspension was plated on 2xYT agar plates
supplemented with 0.1 M glucose and the respective antibiotic. The plate was incubated
over night at 37°C.
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For construction of antigen libraries, the resulting colonies were floated off the agar with
40 ml 2xYT medium. The resulting cell suspension was centrifuged at 3220 x g, 4°C for 15
min. The pellet was resuspended in 2xYT medium containing 20% glycerol and the sample
was stored at -80°C.

2.13.4 Preparation of E. coli cell lysate
A 40 ml starter culture was centrifuged at 3220 x g for 15 min and the pellet was
resuspended in 40 ml PBS. The pellet was washed two more times with 40 ml PBS. Cell
lysis was performed by the application of ultrasound to the sample with a power output of
65% (Sonotrode MS73) for 5 cycles. The resulting suspension was stored at
-20°C.

2.13.5 Affinity-Selection of antigen-phage from libraries
2.13.5.1 Production of the helperphage Hyperphage
A starter culture of E. coli DH5α 409-1 (K02) was incubated over night at 37°C and
250 rpm in 2xYT-GK medium. 400 ml 2xYT-GK were inoculated with 200 µl starter culture
and induction of Hyperphage production was achieved by addition of 0.5 mM IPTG. The
culture was incubated at 30°C and 250 rpm for 24 hours. Afterwards, the cell suspension
was centrifuged at 6000 x g, 4°C for 20 min and the supernatant was transferred into a
fresh tube. For precipitation of the phage 1/5 volume PEG/NaCl was added to the
suspension which was subsequently incubated on ice at 4°C over night. The phage were
then pelleted by centrifugation at 10,000 x g, 4°C for 1 h. The supernatant was discarded
and the pellet was resuspended in 20 ml phage dilution buffer and filter sterilized (pore
size 0.45 µm). Again 1/5 volume PEG/NaCl was added and the sample was incubated on
ice for 1 h followed by a centrifugation at 20,000 x g, 4°C for 20 min. The resulting pellet
was resuspended in 5 ml phage dilution buffer and the Hyperphage suspension was
stored at 4°C and subject to titration.
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2.13.5.2 Packaging of antigen-phage libraries
400 ml 2xYT-GA medium were inoculated with 1 ml from a glycerol stock containing the
respective library and the culture was grown at 37°C and 250 rpm until an OD600 of 0.5
was reached. 25 ml from that culture were transferred to 50 ml reaction tubes and infected
with 2.5 x 1011 CFU Hyperphage. Infection was achieved by incubating at 37°C for 30 min
followed by a second incubation for 30 min at 37°C and 250 rpm. After centrifugation at
3220 x g for 10 min the cell pellet was resuspended in 400 ml 2xYT-AK and the culture
was incubated over night at 30°C and 250 rpm. Precipitation of the phage particles was
performed as described above for the production of Hyperphage. The packaged library
was stored at 4°C in 2 ml screw top vials and subject to titration.

2.13.5.3 Determination of phage titers
50 ml 2xYT-T medium were inoculated with 200 µl of an E. coli XL1 blue MRF’ or an
E. coli TOP10F’ starter culture and the culture was grown at 37°C and 250 rpm until an
OD600 of 0.5 was reached. To determine the phage titers after packaging of a library or of
the eluted phage after a panning round, 10 µl of the phage sample diluted in phage dilution
buffer were added to 50 µl E. coli culture and the samples were incubated at 37°C for 30
min. Dilutions were prepared starting at 10-2 and continuing in steps of two orders of
magnitude until a dilution of 10-10 was reached. After the 30 min incubation 10 µl of each
dilution were plated in triplicate, air-dried and incubated at 37°C over night. Additionally, a
positive control, as well as negative controls containing cells only, cells plus phage dilution
buffer and phage only, were plated.

2.13.5.4 Panning
For the specific selection of immunogenic antigen-phage mouse α-human IgG (Fc specific)
monoclonal antibody was diluted 1:5000 in carbonate buffer and 100 µl were immobilized
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in the well of a MTP (Costar) at 4°C overnight. In parallel, human blood serum was preincubated at 4°C overnight as outlined in the following table.
Table 2-15: Composition of the serum pre-incubation mixture

Component
Patient serum
Hyperphage
E. coli cell lysate
2% MPBST

Concentration
1:10
1 x 1011 phage/ml
10%
To adjust volume

After coating overnight all wells of the MTP were emptied and blocked with 350 µl
2% MPBST for 1.5 h at room temperature followed by three washing steps with PBST
using an ELISA washer. Next, the pre-incubated patient serum was filled into the wells and
incubated at room temperature for 2 h followed by three washing steps with PBST. After
capturing the serum antibodies, 200 µl of the packaged antigen phage from the library or
the previous panning round were filled into the wells and the MTPs were incubated for 2 h
at room temperature. This incubation was followed by 10 x N stringent washing steps with
PBST where N = number of the panning round. Specifically bound phage particles were
eluted by addition of 200 µl Trypsin solution (10 µg/ml) to each well and incubation at 37°C
for 30 min. 190 µl of the eluted phage were used to reinfect E. coli TOP10F’ and amplify
the phage. The remaining 10 µl were used for titration of the eluted phage. In each
selection experiment three rounds of panning were performed.

2.13.5.5 Infection of E. coli and production of antigen-phage
To amplify eluted phage 50 ml 2xYT-T medium were inoculated with 200 µl of an E. coli
TOP10F’ starter culture and the culture was grown at 37°C and 250 rpm until an OD600 of
0.5 was reached. To 20 ml of that culture the eluted phage were added and the mixture
was incubated at 37°C for 30 min followed by a second incubation for 30 min at 37°C and
250 rpm. Next, the re-infected cells were pelleted by centrifugation at 3220 x g for 10 min.
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The pellet was resuspended in 250 µl 2xYT medium and plated on a 15 cm 2xYT-GA agar
plate. The plate was incubated at 37°C overnight.
Colonies were floated off the agar plate using 5 ml 2xYT medium. To 1 ml of the cell
suspension 300 µl 80% glycerol were added and the sample was stored at -80°C.
Approximately 250 µl of the cell suspension were used to inoculate 50 ml 2xYT-GA
medium to an OD600 of 0.05 to 0.09. The culture was subsequently grown at 37°C and 250
rpm until an OD600 of 0.5 was reached. 5 ml of this culture were infected with 5 x 1011
Hyperphage particles by incubation at 37°C for 30 min followed by a second incubation for
30 min at 37°C and 250 rpm. The cells were pelleted at 3220 x g for 10 min and the pellet
resuspended in 30 ml 2xYT-AK followed by an incubation at 30°C and 250 rpm overnight.
To precipitate the phage particles, cells were pelleted at 3220 x g for 10 min and the
supernatant was mixed with 1/5 volume PEG/NaCl and incubated on a rocker on ice for 1
h. After centrifugation at 20,000 x g, 4°C for 1 h the pellet was resuspended in 10 ml
phage dilution buffer and filter sterilized (pore size 0.45 µm). Again 1/5 volume PEG/NaCl
was added and the suspension incubated on ice on a rocker for 1 h followed by a
centrifugation step at 20,000 x g, 4°C for 1 h. The pellet containing the phage particles was
resuspended in 500 µl phage dilution buffer and stored at 4°C until it was used in the next
panning round. 10 µl were used to titer the amplified phage.

2.13.5.6 Production of antigen-phage in microtiter plates
The wells of a microtiter plate (96 well, flat bottom, Sarstedt) were filled with 150 µl 2xYTGA medium and each well was inoculated with a single colony resulting from the third
panning round of an antigen-phage selection experiment. As negative control the wells H3
and H6 were not inoculated (master plate). A previously validated positive control was not
available. The plate was incubated overnight at 37°C and 300 rpm. A new microtiter plate
(96 Well, flat bottom, Sarstedt) was filled with 150 µl 2xYT-GA medium and each well was
inoculated with 10 µl from the respective well of the master plate and incubated for exactly
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2 h at 37°C and 300 rpm. Next, 5 x 109 Hyperphage particles were added to each well and
the plate was incubated at 37°C for 30 min followed by a second 30 min incubation at
37°C and 300 rpm. Subsequently the bacteria were pelleted by centrifugation at 3220 x g
for 10 min and the supernatant was discarded. The pellets were resuspended in 150 µl
2xYT-AK and the plate was incubated at 37°C and 300 rpm overnight.
Bacteria in the master plate were pelleted at 3220 x g for 10 min and the supernatant was
discarded. The pellets were resuspended in 2xYT-GA medium containing 20% glycerol
and the master plate was stored at -80°C.
The production plate was centrifuged at 3220 x g for 10 min and the supernatants were
transferred to a fresh microtiter plate (96 Well, flat bottom, Sarstedt). 40 µl PEG/NaCl were
added to each well and the plate was incubated on ice at 4°C overnight. Phage particles
were pelleted by centrifugation at 3220 x g for 1 h at 4°C. The supernatants were
discarded and the phage pellets resuspended in 150 µl phage dilution buffer. The plate
was centrifuged again at 3220 x g for 10 min to pellet remaining bacteria and supernatants
were transferred to a fresh microtiter plate (96 Well Polypropylene, U-shaped, Greiner Bioone).

2.14 Molecular Biological Methods
2.14.1 Preparation of Plasmid DNA from E. coli
Preparation of plasmid DNA was performed using the peqGOLD Miniprep Kit I (peqlab,
Erlangen). E. coli carrying the plasmid of interest were cultured in 5 ml 2xYT-GA medium
at 37°C and 250 rpm overnight. The cells were harvested by centrifugation at 5000 x g for
10 min and plasmid DNA was isolated according to the supplier’s instructions.
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2.14.2 DNA Amplification via Colony Polymerase Chain Reaction (CPCR)
A colony PCR was performed after construction of the antigen libraries to obtain an
overview of the distribution of different insert sizes of each library. The DNA template
originated from a single bacterial colony which was picked with a sterile pipette tip and
directly inoculated into the aliquoted PCR master mix. The polymerase used was GoTaqDNA-Polymerase. PCR approaches were 10 µl in volume containing one-fifth of the 5x
GoTaq Buffer as well as 200 µM dATP, dCTP, dGTP and dTTP. The final concentration of
each primer used was 500 nM and each approach contained 0.025 U GoTaq-DNAPolymerase. The PCR program is summarized in the following table.
Table 2-16: PCR program used for colony PCR analysis

Cycles
1
24
1
1

Temperature (°C)
95
94
56
72
72
16

Description
Melting of the DNA
Melting of the DNA
Primer Annealing
Elongation
Final Elongation
Storage

Duration
120
15
20
90
300
∞

s
s
s
s
s

2.14.3 Preparation of mRNA from tick salivary glands
Preparation of mRNA was performed using the Illustra mRNA purification Kit (GE
Healthcare). Adult or nymphal Ixodes scapularis were allowed to feed on a rabbit or rodent
host for 18 h. Subsequently, the salivary glands were extracted as outlined in section 2.8.3
and directly transferred into mRNA Extraction Buffer (GE Healthcare). The tissues were
homogenized in two cycles of 2 min each at a frequency of 20 Hz using the Tissue Lyser II
(Qiagen). Subsequently, the mRNA was isolated according to the supplier’s instructions.
The mRNA obtained was further purified and concentrated using the RNeasy Mini Elute
clean-up Kit (Qiagen) according to the supplier’s instructions. The mRNA was eluted in a
total volume of 13 µl.
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2.14.4 Conventional cDNA synthesis
To synthesize the first strand cDNA, 13 µl salivary gland mRNA were mixed with 7.5 µg
random hexamer primers and 1.25 µl dNTPs (10 mM). The volume was brought to 16.5 µl
with nuclease free water and the sample was incubated at 70°C for 5 min followed by a 5
min incubation on ice. Next, 5 µl First Strand Buffer (Invitrogen), 2.5 µl DTT (0.1 M) and
1 µl Superscript II Reverse Transcriptase (Invitrogen) were added and the sample was
incubated at 25°C for 10 min followed by 50 min at 42°C. After a final incubation for 15 min
at 70°C the first strand cDNA was either stored at 4°C or directly used for second strand
synthesis.
To synthesize the second strand, the whole first strand sample containing the RNA-DNA
hetero-duplex was mixed with 10 U E. coli DNA Ligase, 40 U E. coli DNA Polymerase I
and 2 U RNase H. 15 µl 10x E. coli Ligase Buffer were added and the volume was
adjusted to 150 µl with nuclease-free water. The sample was vortexed gently and
incubated at 16°C for 2 h. After addition of 10 U T4 DNA Polymerase, the sample was
incubated at 16°C for another 5 min followed by addition of 10 µl of 0.5 M EDTA. The
double

stranded

cDNA

was

isolated

from

this

mixture

by

adding

160 µl

phenol:chloroform:isoamyl alcohol (25:24:1) and thorough shaking. After centrifuging for 5
min at 14,000 x g, the upper aqueous layer was removed and the DNA precipitated by
addition of 70 µl 3 M Sodium Acetate (pH 5.2) and 500 µl ice-cold ethanol. After
centrifuging for 20 min at 14,000 x g, the supernatant was discarded and the pellet washed
once with ice-cold 70% ethanol. Finally the pellet was resuspended in 14 µl nuclease-free
water.

2.14.5 SMART cDNA synthesis
Tick salivary gland derived mRNA was used to generate double-stranded cDNA for
subsequent cloning into pHORF3. To prepare first strand cDNA, 13 µl mRNA (at least
25 ng) were mixed with 1 µl 3’ SMART CDS Primer II A (12 µM) and 1 µl SMART II A
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Oligonucleotide. The mixture was incubated at 72°C for 2 min to abrogate secondary
structures within the mRNA, followed by an incubation on ice for 2 min. After a brief
centrifugation 4 µl 5x First Strand Buffer (Invitrogen), 0.2 µl DTT, 1 µl dNTP Mix (10 mM
each) and 1 µl M-MLV reverse transcriptase (Invitrogen) were added and the mixture was
incubated at 37°C for 1 h yielding first strand cDNA. For the synthesis of the second strand
a long distance PCR was performed using the following master mix:
Table 2-17: Master Mix prepared for the long-distance PCR performed during SMART cDNA synthesis

Component
10x ExTaq Buffer
dNTP Mix (2.5 mM each)
5’ PCR Primer II A (12 µM)
ExTaq DNA Polymerase
dH2O
Total Volume

Volume
5.00
4.00
2.00
0.25
36.75
48.00

µl
µl
µl
µl
µl
µl

Aliquots of 48 µl master mix were filled into PCR tubes and 2 µl of first strand cDNA were
added. The PCR program for the synthesis of the second strand is summarized in the
following table.
Table 2-18: PCR program used for the long-distance PCR

Cycles
1
24
1
1

Temperature (°C)
95
95
65
72
72
4

Description
Melting of the DNA-RNA Hybrid
Melting of the DNA
Primer Annealing
Elongation
Final Elongation
Storage

Duration
60 s
15 s
30 s
6 min
10 min
∞

2.14.6 Restriction Digest of DNA
To eliminate untranslated regions from the full length transcripts obtained from the SMART
cDNA synthesis and to generate blunt ended DNA fragments suitable for cloning into
pHORF3, a restriction enzyme digest using the blunt end cutters AfeI, AluI and CviKI-1
was performed. 30 µl SMART cDNA (~1.7 µg) were mixed with 1.25 U of each of the
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restriction enzymes named above as well as NEBuffer 4 and BSA in a total volume of
100 µl. The sample was incubated at 37°C for 10 min followed by a heat inactivation at
65°C for 20 min.
The phagemid vector pHORF3 was linearized by digestion with the blunt cutting enzyme
PmeI. Incubation was performed at 37°C overnight followed by heat inactivation at 65°C
for 10 min. To avoid religation, the vector was dephosphorylated with 0.5 µl alkaline
phosphatase (calf intestinal phosphatase, CIP) at 37°C for 30 min. Linearized and
dephosphorylated vector was cleaned up using the NucleoSpin Kit (Macherey Nagel) and
stored at -20°C.

2.14.7 DNA polishing
To obtain blunt ended DNA fragments for cloning of cDNA from the conventional cDNA
synthesis into pHORF3, the DNA needed to be polished. To achieve this, the cDNA was
mixed with 1mM dNTPs, 15 U T4 DNA Polymerase and 5 µg BSA. Also 5 µl NEBuffer 2
was added and the volume brought to 50 µl. The sample was incubated at 25°C for 10 min
followed by the addition of 12.5 U Large Klenow Fragment and another incubation at 25°C
for 10 min followed by a 2 h incubation at 16°C. The blunt-ended DNA was cleaned up
using the NucleoSpin Kit (Macherey Nagel).

2.14.8 Agarose Gel Electrophoresis
In an agarose gel ectrophoresis, DNA fragments were separated in an electric field,
proportional to the negative logarithm of their molecular mass. Thus, 1% (w/v) agarose
gels were supplemented with 10 µl ethidium bromide solution per 35 ml of gel and the
separation was performed at a constant voltage of 120 V for 30 min in TAE buffer.
Documentation of the DNA fragments was performed under UV radiation (λ = 312 nm)
using a video camera.
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2.14.9 DNA Ligation
For ligations, generally 500 ng of linearized, dephosphorylated pHORF3 vector were used
with a 10-fold molecular excess of insert. The amount of insert needed to achieve this 10fold excess was calculated using the following formula.

ݐݎ݁ݏ݊ܫሾ݊݃ሿ ൌ

ܸ݊݃݁ܿ ݎݐൈ ܾ݇ݐݎ݁ݏ݊ܫ
ൈ ͳͲ
ܾܸ݇݁ܿݎݐ

Ligations were performed in total volumes of 60 µl using 3 U of T4 DNA Ligase (Promega).
The samples were incubated overnight at 16°C and subsequently cleaned using the
NucleoSpin Kit (Macherey Nagel).

2.15 Biochemical Methods
2.15.1 Bead Coupling Assay
To enrich serum antibodies specific for salivary gland homogenate (SGH), 2 x 107 Carboxy
Beads (Dynabeads, Invitrogen) were washed twice with 1 ml PBST and twice with 0.5 ml
NaAc buffer (pH 4.5) by rotating for 5 min. Next 100 µl EDC and 100 µl NHS were added
and the beads were rotated for 10 min at room temperature followed by another two wash
steps with 0.5 ml NaAc buffer (pH 4.5) and 5 min of rotation each. 20 µg SGH (1 µg/106
beads) were diluted in 200 µl NaAc buffer and incubated with the beads under rotation for
20 min at room temperature. Subsequently, the beads were washed three times with 1 ml
PBST followed by a 2 h rotation with 1 ml 100 mM ethanol amine. After this blocking step
the beads were washed three times with 1 ml PBST, once with 1 ml PBS followed by an
equilibration in 1 ml 0.1 M glycine/HCl pH 2.2. The beads were washed another three
times with 1 ml PBS and incubated with 400 µl of a 1:1 serum-PBS dilution under rotation
at 4°C over night. Next, the beads were washed three times with 1 ml PBS and the serum
antibodies were eluted by incubation with 150 µl 0.1 M glycine/HCl pH 2.2 under rotation
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for 15 min at room temperature. The supernatant was neutralized by addition of 45 µl
0.5 M Tris-HCl pH 8 and brought to a total volume of 300 µl by adding PBS. The eluted
antibodies were stored at 4°C until they were used in a subsequent capture or titration
ELISA.

2.15.2 Enzyme Linked Immunosorbent Assay (ELISA)
2.15.2.1 Capture ELISA
Capture antibody goat α-human IgG, polyvalent (Sigma I1761) was diluted 1:6700 with
carbonate buffer and 100 µl were coated in each well of a MTP (Costar) overnight at 4°C.
All wells were emptied and blocked with 350 µl 2% MPBST for 1.5 h at room temperature
followed by three washing steps with PBST using an ELISA washer. Next, a dilution series
of a protein N standard in 2% MPBST was prepared according to the supplier’s
instructions and 100 µl of the respective dilution were filled into the wells and incubated at
room temperature for 2 h. At the same time different volumes of eluted serum antibodies
from the bead coupling assay diluted with 2% MPBST were also incubated in wells with
immobilized capture antibody. After three washing steps with PBST using an ELISA
washer, goat α-human IgG (Fc specific) peroxidase conjugated antibody (Sigma, A0170)
was diluted 1:70,000 in 2% MPBST and aliquots of 100 µl were incubated in each well for
1 h at room temperature followed by three washing steps with PBST using an ELISA
washer. Finally 100 µl substrate solution (TMB-A and TMB-B, ratio 19:1) were added to
each well. The staining reaction was allowed to take place for 5 to 20 min at room
temperature and was stopped by addition of 100 µl 1 N H2SO4.

2.15.2.2 Screening ELISA
A screening ELISA was performed to analyze the interaction of patient serum with the
antigen displaying phage obtained after three rounds of panning. Hence, mouse α-M13
capture antibody (Progen) was diluted 1:400 in carbonate buffer and aliquots of 100 µl
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were incubated in the wells of a MTP (Costar) overnight at 4°C. At the same time a serum
pre-incubation mixture was set up as outlined in section 2.13.5.4 and incubated at 4°C
overnight. All wells of the MTP were emptied and blocked with 2% MPBST for 1.5 h at
room temperature followed by three washing steps with PBST using an ELISA washer.
Next, 50 µl monoclonal antigen displaying phage, produced in MTPs (see section 2.13.5.6)
were diluted with 50 µl 2% MPBST, filled into the wells and incubated at room temperature
for 2 h. As negative controls 1 x 1010 Hyperphage (instead of antigen displaying phage)
were added to the wells H3 and H6. After three washing steps with PBST using an ELISA
washer 100 µl pre-incubated serum were filled into each well and incubated for 2 h at room
temperature. After another three washing steps with PBST goat α-human IgG (Fc specific)
peroxidase conjugated detection antibody was diluted 1:70,000 in 2% MPBST and 100 µl
aliquots were filled into each well. As positive control mouse α-M13 peroxidase conjugated
detection antibody (GE Healthcare) was diluted 1:40,000 in 2% MPBST and 100 µl were
filled into wells H9 and H12 and incubated at room temperature for 1 h. After three
washing steps with PBST using an ELISA washer 100 µl substrate solution (TMB-A and
TMB-B, ratio 19:1) were added to each well. Staining reactions are allowed to take place
for 5 to 20 min at room temperature and were stopped by adding 100 µl 1 N H2SO4.

2.15.2.3 Titration ELISA
200 ng salivary gland homogenate (SGH) from 18 h fed Ixodes scapularis nymphs diluted
in carbonate buffer were immobilized in the wells of a microtiter plate (Costar) at 4°C
overnight. Wells were blocked with 350 µl 2% MPBST for 1.5 h at room temperature
followed by three washing steps with PBST using an ELISA washer. As negative controls,
wells were solely blocked without the immobilization of SGH. Patient serum was diluted in
2% MPBST (range of 1:10 to 1:10,000) and incubated in aliquots of 100 µl in each well for
2 h at room temperature followed by three washing steps with PBST using an ELISA
washer. Goat α-human IgG (Fc specific) peroxidase conjugated antibody (Sigma, A0170)
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was diluted 1:70,000 in 2% MPBST and incubated in aliquots of 100 µl in each well for 1 h
at room temperature followed by three washing steps with PBST using an ELISA washer.
As an additional negative control the detection antibody was incubated in a well with
immobilized SGH that had previously not been incubated with patient serum. Finally,
100 µl substrate solution (TMB-A and TMB-B, ratio 19:1) were added to each well and
staining reactions were allowed to take place for 5 to 20 min at room temperature before
being stopped by adding 100 µl 1 N H2SO4.

2.15.3 Protein analysis via SDS Polyacrylamide Gel Electrophoresis (SDS-PAGE)
The discontinuous SDS-PAGE was performed as outlined by Laemmli (Laemmli, 1970)
under consideration of the modifications made by Righetti (Righetti, 1990) using a stacking
gel to focus the proteins with a subsequent separation in a separating gel. The protein
samples were mixed with SDS sample buffer followed by an incubation at 95°C for 5 min.
After a short incubation on ice, the samples were run on a 12% polyacrylamide gel. The
electrophoresis was performed at 200 V and 400 mA for 45 min. The composition of the
stacking and separating gel is summarized in the following tables.
Table 2-19: Recipe for a SDS-PAGE stacking gel

Component
dH2O
Acrylamide solution
Tris
SDS solution
APS solution
TEMED

Volume
1.00
0.26
0.20
15
15
2
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ml
ml
ml
µl
µl
µl

Table 2-20: Recipe for a SDS-PAGE separating gel

Component
dH2O
Acrylamide solution
Tris
SDS solution
APS solution
TEMED

Volume
1.3
1.6
1.0
40
40
2

ml
ml
ml
µl
µl
µl

2.15.4 Western Blot
To transfer proteins previously separated in a SDS-PAGE to a PVDF membrane, a
Western Blot was performed. Hence, a piece of filter paper was soaked in blotting buffer
and placed on the blotting machine. On the filter paper the PVDF membrane, which was
previously equilibrated in methanol, was placed followed by the gel and another piece of
soaked filter paper. The protein transfer from the gel to the PVDF membrane was
achieved by application of an electric field at 20 V and a maximum of 770 mA for 35 min.

2.15.5 Immunostain
After the transfer of proteins to the PVDF membrane, an immunostain was performed.
First the membrane was blocked for 1 h in 2% MPBST on a rocker to avoid unspecific
binding. Next, the membrane was incubated with goat α-human IgG (Fc specific)
phosphatase conjugated (Dianova) diluted 1:5000 in 2% MPBST for 1 h at room
temperature. After two wash steps with substrate buffer the membrane was incubated in
10 ml substrate buffer supplemented with 100 µl NBT and 100 µl BCIP for 15 min at room
temperature. The reaction was stopped by discarding the substrate solution and two
subsequent wash steps with water. Finally, the membrane was dried between paper
towels and documented using a digital scanner.
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3 Results
3.1 Analysis of human blood sera
3.1.1

Determination of the abundance of antibodies specific for salivary gland
homogenate (SGH)

For this study, human blood sera from seven different individuals were analyzed to assess
their titers of antibodies specific for salivary gland homogenate (SGH) of 18 hour fed
Ixodes scapularis nymphs by titration ELISA. Prior to this analysis, patients were grouped
as either tick bite sensitized by multiple tick bites or tick bite naïve. Grouping was
performed according to the patient’s own statements and is summarized in the following
table.
Table 3-1: Summary of human patient sera available for this study and tick bite status according to the
patient’s own statement

Patient
1
2
3
4
10
11
12

Tick bite status
naïve
sensitized
sensitized
sensitized
naïve
sensitized
sensitized

To analyze serum IgG binding to SGH at different serum dilutions, a titration ELISA was
performed. As a negative control, serum at the lowest dilution of 1:10 was administered to
blocked wells without SGH.
Results depicted in Figure 3-1 reveal two important facts about the human blood sera
analyzed. For all sera analyzed the signal decreased very rapidly with further dilution of
the sample, indicating low titers of SGH specific antibodies of the IgG isotype.
Secondly, it has to be noted that different sera reveal very different signal-to-noise ratios.
A high background signal, referring to higher unspecific binding capacity, would be
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undesirable in subsequent phage-display pannings since this might lead to amplification
and selection of non-immunogenic phage clones. Among the serum samples analyzed,
patient 2 and patient 12 exhibited the highest signal to noise ratio and appeared most
promising for further analyses to identify immunogenic tick salivary proteins. Nevertheless,
additional information verifying the presence of anti-SGH antibodies needs to be obtained.

Figure 3-1: Titration ELISA to assay the reactivity of IgG present in human blood sera to SGH from 18 h fed
I. scapularis nymphs

3.1.2

Specific enrichment of anti-SGH antibodies

To enrich antibodies from the human blood sera that are specific for SGH, a bead coupling
assay was performed. In this approach, SGH obtained from 18 h fed I. scapularis nymphs
was coupled to carboxy beads (Dynabeads, Invitrogen). To analyze the immobilization of
SGH on the beads, the protein sample was visualized on an SDS-Polyacrylamide gel with
subsequent silver staining before and after incubation with the magnetic beads.
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Figure 3-2: SDS-PAGE of different amounts of SGH with subsequent silver staining, Lane M: Precision Plus
unstained Protein Marker, Lane 1: 1 µg, lane 2: 500 ng, lane 3: 250 ng, lane 4: 100 ng, lane 5: 50 ng, lane 6:
0 ng

The silver staining (Figure 3-2) visualized different amounts of SGH on the SDS gel
revealing the majority of proteins having a molecular mass between 25 kDa and 75 kDa.
Importantly, it can be observed that the amount of 1 µg of SGH protein can be visualized
very efficiently with this type of assay, thus providing the basis for the concentration of
SGH needed for carboxy bead incubation. In the case of unsuccessful binding of SGH to
the beads, the concentration in the supernatant needs to be high enough to reveal
unsuccessful binding by silver gel analysis. Accordingly, the carboxy beads were
incubated with 0.1 µg/µl SGH. 16 µl of the resulting supernatants were analyzed on a gel
(Figure 3-3). Additionally, control beads were prepared without SGH. SDS-PAGE and silver
staining analysis of the supernatants (Figure 3-3) confirmed successful binding of SGH to
the carboxy beads since the supernatants showed no remaining protein. This suggests
that the whole amount of SGH was coupled to the beads.
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Figure 3-3: SDS-PAGE of supernatants from the immobilization of SGH to carboxy beads. Lane M: Precision
Plus unstained Protein Marker, Lane 1+2: supernatant from SGH coupling, Lane 3+4: supernatant from control
beads without SGH

Following successful immobilization of SGH, carboxy beads were incubated overnight with
human blood serum pooled from patients 2 and 12, then washed stringently and
resuspended in PBS. From this bead suspension, distinct volumes were analyzed for
antibody binding by ELISA using peroxidase conjugated α-human IgG (Fc specific)
detection antibody.
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Figure 3-4: ELISA on magnetic beads that were previously coupled with SGH and incubated with pooled
human blood serum from patient 2 and 12. Control beads were solely blocked with ethanol amine prior to
incubation with human blood serum. Human IgG bound to the beads were detected using an α-human IgG (Fc
specific) HRP conjugated antibody.

The ELISA performed directly on the magnetic beads (Figure 3-4) confirmed the
accumulation of serum antibodies on beads previously coupled with SGH. Antibody
binding to the control beads also could be observed, although to a far lesser extent,
suggesting that antibodies specifically recognizing SGH were enriched on the SGH
coupled beads.
In the next step, the antibodies captured on the beads were eluted with an acidic solution
of 0.1 M glycine/HCl, pH 2.2. After a short incubation, the supernatant was separated from
the magnetic beads and neutralized. The resulting aqueous solution containing the eluted
antibodies was analyzed on a silver gel as well as on a western blot. On an SDS gel
(Figure 3-5) different amounts of eluate from either SGH coupled beads or control beads
previously incubated with human serum were analyzed. In this SDS-PAGE, performed
under reducing conditions, the bands for IgG antibodies were expected to run at 50 kDa
(heavy chain) and 25 kDa (light chain), as clearly observed for the positive control.
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Figure 3-5: Silver gel analysis of antibodies eluted from SGH coupled beads as well as control beads.
Different volumes of eluate were applied to the gel. Lane M: Precision Plus unstained Protein Marker, Lane 1:
16 µl eluate from SGH beads, Lane 2: 10 µl eluate from SGH beads, Lane 3: 5 µl eluate from SGH beads,
Lane 4: 16 µl eluate from control beads, Lane 5: 10 µl eluate from control beads, Lane 6: 5 µl eluate from
control beads, Lane (+): IgG positive control, 126 ng

To detect the eluted antibodies, the characteristic IgG bands can most prominently be
observed for the largest amounts of eluate applied to the gel (Lanes 1 and 4 in Figure 3-5).
It also can be noted that the amount of antibodies eluted from the SGH coupled beads is
larger than the amount eluted from the control beads. Western blot analysis of the same
samples led to detection of IgG bands at the expected height of the 50 kDa marker band
(Figure 3-6).
In conclusion, the results obtained from the bead coupling assay validate its application for
enriching antibodies from human blood sera that specifically bind salivary gland
homogenate from 18 hour fed I. scapularis nymphs. The assay can be used to directly
analyze the content of SGH specific antibodies in various serum samples.
To justify the subsequent use of human blood sera in phage display pannings for
identifying immunogenic tick salivary proteins, the bead coupling assay was used to verify
the presence of anti-tick salivary protein antibodies in the serum samples. Due to
limitations in the availability of SGH, only two different sera could be analyzed. Thus,
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patient 2 and patient 12 were selected, according to the findings from the titration ELISA
(Figure 3-1).

Figure 3-6: Wetsern blot analysis of antibodies eluted from SGH coupled beads as well as control beads.
Different volumes of eluate were applied to the gel. Lane M: Precision Plus Dual Color Protein Marker, Lane 1:
16 µl eluate from SGH beads, Lane 2: 10 µl eluate from SGH beads, Lane 3: 5 µl eluate from SGH beads,
Lane 4: 16 µl eluate from control beads, Lane 5: 10 µl eluate from control beads, Lane 6: 5 µl eluate from
control beads, Lane (+): IgG positive control, 126 ng. After blotting the antibodies were detected using an αhuman IgG (Fc specific) peroxidase conjugated detection antibody.

3.1.3

Analysis of selected human blood sera for specific anti-tick antibodies

The bead coupling assay outlined above was repeated using sera from patients 2 and 12,
respectively. The amount of antibodies eluted from SGH coupled- and control beads after
incubation with serum from either patient 2 or patient 12 was determined by a capture
ELISA and compared to a Protein N Standard. Additionally, the IgG content of the crude
serum was determined. Results of the capture ELISA are summarized in Table 3-2.
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Table 3-2: Determination of the IgG concentrations of crude serum, eluate from SGH coupled beads and
eluate from control beads of patients 2 and 12.

Serum

Crude serum

Patient 2
Patient 12

9.39 mg/ml
11.04 mg/ml

Antibody Concentration of
Eluate from SGH
Eluate from control
coupled beads
beads
85.63 ng/ml
42.82 ng/ml
375.50 ng/ml
104.07 ng/ml

Determining exact concentrations of IgG antibodies permitted normalization of the
amounts of the respective antibodies applied in a repeated titration ELISA on SGH. This
assay was used to reveal the specific binding capacity of enriched antibodies from the
SGH coupled beads as compared to the crude serum and the eluate from the control
beads. This assay (Figure 3-7) confirmed the successful enrichment of anti-SGH antibodies
from the sera of patients 2 and 12. When the same amount of antibodies from either crude
serum or the control eluate was applied to SGH, no significant signal could be observed.
Thus, it can be concluded that both sera analyzed do contain SGH specific antibodies.
This finding justifies use of the sera for subsequent phage display screenings to identify
immunologically relevant antigens.
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Figure 3-7: Titration ELISA of normalized crude serum as well as eluted antibodies from SGH coupled beads
and control beads from patient 2 (A) and patient 12 (B) on salivary gland homogenate
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3.2 Analysis of an antigen library from adult Ixodes scapularis
3.2.1

Construction of an antigen library from adult Ixodes scapularis

For the construction of an antigen library based on transcripts from salivary glands of adult
I. scapularis, female ticks were allowed to feed on a rabbit host for 18 h. After removing
ticks from the rabbit, tick salivary glands were dissected followed by mRNA extractions
and conventional cDNA synthesis using random hexamer primers. The blunt ended cDNA
was analyzed on an agarose gel and subsequently cloned into the phagemid vector
pHORF3 to yield the library. E. coli TOP10F’ were transformed with this library by
electroporation. After determination of the primary diversity, the library was packaged into
phage particles using the helperphage M13K07ΔgIII (Hyperphage) to enrich for open
reading frames.

Figure 3-8: Based on mRNA from salivary glands of 18 h fed adult I. scapularis cDNA was synthesized using
random hexamer primers (A). This cDNA was blunt ended, cloned into pHORF3 and E. coli TOP10F’ were
transformed with this library; from the resulting colonies 20 random clones were picked and analyzed in a
CPCR, (B) M: Marker, (-): empty pHORF3 as negative control

Examining the double-stranded cDNA on an agarose gel (Figure 3-8 (A)) showed a smear
ranging from 200 bp to approximately 1500 bp. This broad distribution of cDNA fragments
satisfies criteria for antigen library construction with respect to yielding a high diversity of
different antigens. A broader the distribution of different inserts indicates higher diversity of
the library. Based on this, the insert sizes of 20 randomly-picked clones were analyzed
and revealed a broad distribution of different insert sizes (Figure 3-8 (B)). Also, nearly 100%
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of the clones appeared to carry inserts, further fulfilling the criteria for antigen library
construction.
To further assess the characteristics of the library, some 20 random clones were subjected
to sequence analysis to provide insight into what is encoded within the library. A BLASTn
analysis using these sequences revealed that most hits referred to database entries from
Ixodes scapularis designated as “tandem repeats”, and no known function could be linked
to those sequences. Furthermore, the library contained some rRNA sequences, which was
unwanted due to their non-protein-coding nature. There were some sequences that
encoded putative salivary proteins, giving the library its significance. The most important
characteristics to evaluating the quality of the library are summarized in Table 3-3.
Table 3-3: Summary of important characteristics to evaluate the quality of the antigen library derived from
salivary glands of adult ticks

Ticks
needed

Diversity

Titer after
packaging

Effort

500 - 700

1 x 106

5 x 109 to
2 x 1011

high

3.2.2

Insert (%)
>95%

Random sequencing
Many “tandem repeat”
sequences
Some rRNAs

Panning of an antigen library from adult Ixodes scapularis

To identify immunogenic polypeptides from tick salivary glands of adult I. scapularis, the
antigen library was screened against human blood serum. For this purpose, the library
discussed above was packaged into phage particles that display the respective salivary
protein on their surface. Primary packaging of the library with Hyperphage yielded a titer of
5 x 109 CFU/ml. A total of three panning rounds was performed to enrich for immunogenic
peptides. The pannings were performed in MTPs in which IgG antibodies from patient sera
were captured, followed by incubation with the antigen displaying phage and stringent
washing. Prior to their application, the human blood sera had been pre-incubated with
E. coli cell lysate and Hyperphage to prevent enrichment of unspecific phage due to
antibodies recognizing the phage particle itself and not the peptide displayed. Over the
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course of the three panning rounds, the titer of eluted phage after each round was
monitored for an indication of successful enrichment.
The first two pannings performed with the antigen library derived from adult I. scapularis
salivary glands resulted in titers of less than 10³ eluted phage after the first panning round.
Consequently, these pannings were cancelled. Packaging of the library into phage
particles was repeated and yielded an increase in titer of almost two orders of magnitude
as compared to the first packaging (also see Table 3-3).
The newly packaged library was used for a new panning and the titers of eluted phage
were monitored after each panning round (Figure 3-9). The titers of eluted phage increased
with subsequent panning rounds, suggesting an enrichment of phage particles displaying
potentially immunogenic peptides.

Figure 3-9: Increasing titers of eluted phage from the adult tick antigen library after each panning round. The
increase of eluted phage after each round indicates an enrichment of specific phage clones.

After the third panning round, 94 random clones were picked and grown in a microtiter
plate (MTP) to subsequently produce monoclonal antigen-phage for a screening ELISA.
The wells H3 and H6 remained empty as negative controls. Clones inoculated into wells
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H9 and H12 were later on not used for screening with patient serum but as positive
controls for a successful phage production.
A screening ELISA performed to test for immunogenic polypeptides displayed on the
phage particles was performed in two different ways. In the first approach, monoclonal
antigen-phage were immobilized in the wells of a MTP directly. Subsequently, preincubated patient serum was added to the phage. After stringent washing, human
antibodies were detected by application of peroxidase -conjugated α-human IgG (Fc
specific) antibody.
In the second approach, the monoclonal phage particles were not coated directly to the
wells of a MTP but instead were captured using a monoclonal mouse α-M13 antibody. The
remaining procedure of the incubation and detection was essentially the same.
For negative controls in the screening ELISA, Hyperphage was added to the respective
wells (H3 and H6) instead of monoclonal antigen-displaying phage particles. Thus, the
only difference between the negative control and the experimental approaches was the
display of the respective tick polypeptide on the phage surface. As positive control, the
presence of phage particles was assayed by applying an peroxidase-conjugated α-M13
detection antibody. Positive controls were not incubated with human blood serum.
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Figure 3-10: Results of the screening ELISA from the randomly picked clones resulting from the third panning
round of the antigen library derived from adult I. scapularis salivary glands. In (A) the phage particles were
coated directly whereas in (B) the phage particles were captured. Negative Control: Hyperphage; Positive
control: detection of phage particles

Results of the screening ELISA revealed no immunogenic peptides displayed on any of
the phage analyzed (Figure 3-10). However, production and immobilization of the
monoclonal antigen-phage was successful as confirmed by the positive control. One
finding that can be derived from the experiments shown is that there is a difference for this
assay with regards to the comparison of directly coated or captured phage. In the case of
captured phage particles, it can be noted that the general background signal is lower. This
phenomenon also was observed previously (Havlik, personal correspondence) and is
confirmed here. Consequently, for all screening ELISAs performed hereafter, the phage
particles were always captured. To solve the issue of unsuccessful panning the
component that was to be changed most easily was addressed and a new antigen library
was constructed.
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3.3 Analysis of an antigen library from nymphal Ixodes scapularis
3.3.1

Construction of an antigen library from nymphal Ixodes scapularis

Since nymphal ticks are of higher relevance with respect to transmission of pathogens,
primarily due to their smaller size, an antigen library based on nymphal tick salivary glands
was constructed. The general procedure was the same as for the adult antigen library
(section 3.2.1), however, a different strategy for cDNA synthesis was chosen to overcome
a limitation in the availability of salivary gland mRNA.
Ixodes scapularis nymphs were allowed to feed on a mouse or hamster host for 18 hours.
After ticks were pulled off their host, tick salivary glands were dissected and subjected to
mRNA extractions. The mRNA extracted in this process was used to synthesize doublestranded cDNA following the protocol for SMART cDNA synthesis (Clontech, CA). Briefly,
an oligo(dT) Primer with an adapter is used together with a reverse transcriptase. The
reverse transcriptase used needs to have two advanced activities. First, terminal
transferase activity is necessary which leaves a small number of cytosine residues at the
3’ end of the newly synthesized first strand cDNA. Second, template switching activity is
needed. The reaction mixture contains a second primer comprised from 5’ to 3’ of the
adapter sequence followed by a small number of guanidine residues. This primer
recognizes the C residues synthesized by the reverse transcriptase and subsequently acts
as new template to add the adapter sequence to the first-strand cDNA. Finally, a PCR can
be performed using a specific primer for the adapter sequence which allows amplification
of all transcripts. The SMART cDNA that was synthesized was visualized on an agarose
gel.
This protocol, however, leads to full length transcripts containing the stop codon as well as
5’ UTR and 3’ UTR, all of which are unwanted for subsequent cloning into pHORF3. To
avoid these issues, the SMART cDNA was subjected to a restriction enzyme digest using
the three blunt-end cutters AfeI, AluI and CviKI-1, making the digested cDNA was directly
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available for cloning. After cloning into pHORF3, the resulting antigen library was
transformed into E: coli TOP10F’ by electroporation. After determining the primary
diversity, the library was packaged into phage particles using the helperphage
M13K07ΔgIII (Hyperphage) to enrich for open reading frames.

Figure 3-11: Based on mRNA from salivary glands of 18 h fed I. scapularis nymphs, cDNA was synthesized
following the SMART cDNA synthesis protocol (A). This cDNA was subject to a restriction enzyme digest,
cloned into pHORF3 and E. coli TOP10F’ were transformed with this library; from the resulting colonies 20
random clones were picked and analyzed in a CPCR, (B) M: Marker, (-): empty pHORF3 as negative control

Examination of the SMART cDNA visualizes the size of cDNA fragments ranging from
200 bp to more than 1500 bp (Figure 3-11 (A)) revealing a satisfying distribution of different
fragments. Additionally, using the SMART protocol, it was possible to synthesize µg
amounts of cDNA from only ng amounts of mRNA, overcoming the limitation of low
availability of the desired starting material. The distribution of different insert sizes after
cloning into pHORF3 was analyzed by CPCR and subsequent agarose gel electrophoresis
(Figure 3-11 (B)). This analysis revealed a satisfying distribution of different inserts as well
as an insert percentage of close to 100%. Furthermore, the clones also were subjected to
sequence analysis. Performing a BLASTn analysis using the sequences obtained from
randomly picked clones, most sequences could be linked to previously annotated
database entries of Ixodes scapularis salivary proteins. None of the sequences analyzed
referred to the “tandem repeat” entries encountered when analyzing the antigen library
derived from adult ticks (see section 3.2.1). Also, no sequences referring to rRNAs were
found, confirming the specific reverse transcription of poly (A) tailed RNAs only. In
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conclusion, the parameters analyzed to evaluate the quality of the library appear to be very
promising. An overview of the important parameters is given in Table 3-4.
Table 3-4: Summary of important characteristics to evaluate the quality of the antigen library derived from
salivary glands of nymphal ticks

Ticks
needed

Diversity

Titer after
packaging

Effort

Insert (%)

Random sequencing

~50

1 x 106

2 x 1011

low

>95%

Mostly annotated tick
sequences

3.3.2

Panning of an antigen library from nymphal Ixodes scapularis

3.3.2.1 Panning using pooled human blood sera
To identify immunogenic tick salivary proteins, three rounds of panning were performed
using the nymphal antigen library and pooled human blood sera from all patients classified
as sensitized (see Table 3-1). The pooled serum was pre-incubated in a mixture containing
Hyperphage and E. coli cell lysate to prevent enrichment of unspecific phage due to
antibodies recognizing the phage particle itself and not the peptide displayed. Over the
course of the three panning rounds, the titers of eluted phage after each round were
monitored to give an indication of successful enrichment (Figure 3-12). Two pannings were
performed in parallel.
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Figure 3-12: Development of the titers of eluted phage from the nymphal antigen library after each panning
round. The increase of eluted phage after each round indicates the enrichment of specific phage clones.

For both pannings, titers increased with subsequent rounds indicating successful
enrichment of potentially significant clones. To identify immunogenic peptides displayed by
phage, a screening ELISA was performed. After the third panning round 94 random clones
from each panning performed were picked and grown in MTPs to produce monoclonal
antigen-displaying phage. The results of the screening ELISAs are shown in Figure 3-13.
It has to be noted that, despite the promising increase in titers of eluted phage after each
panning round, the screening ELISA did not reveal a positive clone in either of the two
pannings performed. Moreover, none of the signals obtained was significantly higher than
that of the negative control. As with the adult antigen library, unsuccessful production of
the monoclonal phage can be excluded to be the issue, since the positive control gave a
strong signal.
Two critical points for ensuring a successful panning are the amount of anti-tick specific
antibodies in the sera as well as the quality of the antigen library. Since with the nymphal
antigen library all parameters considered to evaluate the quality of the library appear to be
very good (see Table 3-4), it suggested that changes in the use of human blood sera might
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lead to a successful panning. Thus, a second panning was performed using individual
instead of pooled sera.

Figure 3-13: Screening ELISAs of the randomly picked clones after the third panning round. Panning was
performed using the nymphal antigen library and pooled human blood serum from patients previously classified
as sensitized. Negative Control: Hyperphage; Positive control: detection of a random antigen displaying phage
using an α-M13 peroxidase conjugated antibody.

3.3.2.2 Panning using single human blood sera
To identify immunogenic tick salivary proteins, an alternative panning strategy was utilized
in which human blood serum from only one individual was used instead of a serum pool.
Besides this variation, the strategy pursued was essentially the same as outlined
previously. For the following analyses sera from patients 2, 11, 12 and patient X were
used. As outlined for all previous pannings performed, the titers of eluted phage after each
panning round were monitored (Figure 3-14). In all cases a prominent increase in eluted
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phage can be observed, suggesting the successful enrichment of phage particles
displaying potentially immunogenic peptides.

Figure 3-14: Development of the titers of eluted phage from the nymphal antigen library after each panning
round using individual human blood sera. The increase of eluted phage after each round indicates the
enrichment of specific phage clones.

As outlined for previous pannings, after the third panning round, 94 randomly picked
clones were grown in MTPs to produce monoclonal phage particles displaying tick salivary
peptides. The resulting monoclonal phage were used to perform a screening ELISA to
assess for successful enrichment of phage displaying immunogenic peptides.
Results of the screening ELISAs are shown in Figure 3-15. While the pannings performed
with sera from patient 11 (Figure 3-15 (B)) and patient X (Figure 3-15 (D)) resemble the
results seen in all previously performed screening ELISAs, pannings performed with sera
from patient 2 (Figure 3-15 (A)) and patient 12 (Figure 3-15 (C)) led to clones with signal
intensities higher than that of the negative control containing Hyperphage. Signals being
one and a half to twice as high as the signal of the negative control can be considered as
potential clones of interest and eight clones from the panning with patient 2 serum as well
as five clones from the panning with patient 12 serum were selected and subject to
sequence analysis. The sequences obtained were analyzed using the BLASTn algorithm.
The eight clones obtained from patient 2 serum revealed four different inserts. The most
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abundant clone which occurred four times among the eight clones analyzed was carrying
the genetic information for a fragment of Metalloprotease 1 from I. scapularis but also had
significant similarity to metalloproteases from I. pacificus and I. ricinus. The five clones
obtained from panning with patient 12 serum revealed three different inserts. The results
are summarized in Table 3-5.
Table 3-5: Summary of the sequencing analysis of positive clones obtained from panning with individual
patient sera. The inserts found were subject to a BLASTn analysis to determine the nature of the peptide
displayed on the phage.

Derived
from
Patient

Frequency

Insert
size

Accession
Number

Description

Identity

2

1/8

-

-

Sequencing failed

-

2

1/8

64 bp

XM_002406537.1

Ixodes scapularis DNA
ligase, putative, mRNA

100%

2

4/8

118 bp

AY264367.1

2

1/8

43 bp

XM_002403042.1

2

1/8

79 bp

XM_002416616.1

Ixodes scapularis alpha
tubulin, mRNA

99%

12

2/5

-

-

Sequencing failed

-

12

1/5

43 bp

XM_002403042.1

12

1/5

139 bp

XM_002434300.1

12

1/5

79 bp

XM_002416616.1
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Ixodes scapularis salivary
gland metalloprotease
mRNA
Ixodes scapularis 60S
ribosomal protein L14,
putative mRNA

Ixodes scapularis 60S
ribosomal protein L14,
putative, mRNA
Ixodes scapularis E3
ubiquitin protein ligase
Bre1, putative, mRNA
Ixodes scapularis alpha
tubulin, mRNA

92%

100%

100%

99%

99%

Figure 3-15: Screening ELISAs of the randomly picked clones after the third panning round. The pannings
were performed using the nymphal antigen library and individual human blood sera. (A) Patient 2, (B) Patient
11, (C) Patient 12, (D) Patient X; Negative Control: Hyperphage; Positive control: detection of a random
antigen displaying phage using an α-M13 peroxidase conjugated antibody.
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3.3.2.3 Verification of binders identified in the pannings
To verify binders that were identified in pannings with individual patient sera and listed in
Table 3-5, the respective phage were newly packaged and subject to a repeated ELISA
using the respective patient serum. As outlined previously, the patient sera were preincubated with E. coli cell lysate and Hyperphage. As negative control, Hyperphage were
captured by an α-M13 antibody instead of antigen displaying phage particles. The clones
that could not be sequenced successfully were designated as “unknown” and included in
the verifying ELISA. The results of the verifying ELISA are shown in Figure 3-16. For all
clones analyzed, it can be observed that the signal is significantly stronger than that of the
negative control. However, signal intensities in general are comparably low as they were
throughout all previously performed analyses.

58

Figure 3-16: ELISA to verify the specific recognition of antigen displaying phage identified in Section 3.3.2.2 by
the respective patient serum; (A) Patient 2; (B) Patient 12; Hyperphage serves as negative control as
previously outlined for the screening ELISA analyses.
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4 Discussion
Due to their capacity for pathogen transmission, ticks pose significant risks to humans,
domestic animals and cattle, resulting in public health concerns as well as economic
losses (Wikel and Alarcon-Chaidez, 2001). Current treatments to relieve tick burdens in
endemic areas are mostly based on the application of acaricides. This strategy, however,
has negative impacts on the environment and agriculture. Additionally, certain tick species
quickly develop insecticide resistance (Willadsen, 2004). Another strategy gaining greater
attention over the past two decades is the idea of anti-tick vaccination (de la Fuente et al.,
2007b; Nuttall et al., 2006). Based on the phenomenon of acquired tick bite immunity
(Trager, 1939), vaccination with molecules present in tick saliva appears to be most
promising when pursuing an anti-tick vaccination approach (Willadsen, 2004).
The goal of this study was to identify Ixodes scapularis salivary antigens that might serve
as novel vaccine candidates for humans. To identify these proteins, a phage display
approach was employed. The screening was designed to identify I. scapularis salivary
antigens that are recognized by antibodies present in human blood sera.

4.1 Analysis of human blood sera
Human blood sera from seven different individuals were available for this study. These
patients had been grouped as being either tick bite sensitive or naïve according to their
own statement. This first classification of the serum samples already states a critical point
when evaluating the sera. Individuals previously bitten by ticks can provide sound
information that they have been in close contact with ticks, thereby imparting significance
to their sera with respect to the presence of anti-tick antibodies. Conversely, individuals
reporting to be tick-bite naïve may still have been bitten by ticks, even multiple times, but
may never have recognized it. An additional issue with the sera used in this study is that it
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is unknown when sensitized patients had last been in contact with ticks. This is an
important factor for the presence of anti-tick specific antibodies in the serum, since titers
decrease after prolonged elapsed time with no tick contact. A titration ELISA was
performed to further assess the reactivity of serum antibodies with SGH. Results obtained
from this assay did not produce a clear distinction between tick bite sensitive and tick
naïve patients, leading to a major limitation: the lack of a validated serum negative control.
In addition to the indistinguishability between tick bite sensitive and naïve blood sera, low
titers of serum antibodies specific for SGH, in general, were another limitation. Following
examination by the titration ELISA the most promising sera were obtained from patients 2
and 12, especially due to their relatively high signal-to-noise ratios. Continued analyses of
these sera using the bead coupling assay to enrich SGH specific antibodies and the
subsequent titration ELISA with these enriched antibodies on SGH confirmed the presence
of SGH specific antibodies. Nevertheless, low antibody titers in general were a limitation to
the experimental design.
The study presented here is the first investigation aiming to identify immunogenic tick
salivary proteins using human immune sera. All studies reviewed in the literature used
sera from laboratory animals or cattle. The advantage of laboratory animals becomes clear
when considering that rabbits for example can be challenged with ticks multiple times in
intervals of two weeks and that serum samples can be taken at the peak point of an
antibody response (Das et al., 2001; Narasimhan et al., 2007a; Schuijt et al., 2011b). Such
highly reactive sera cannot be obtained so easily from humans, somewhat limiting the
usability of human sera. Nevertheless, the observed presence of SGH specific antibodies
together with the patient’s reports of immune responses to tick bites, justifies use of the
serum samples available.
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4.2 Construction of salivary gland antigen libraries
Salivary gland antigen libraries constructed in this work are based on mRNA from the
salivary glands of 18 hour fed I. scapularis. Since these tissues are very small, especially
during early stages of the feeding process, mRNA yields are a limiting factor. Even though
the salivary glands grow and change in morphology during the feeding process (Kaufman,
1989), the early time points are of higher significance with respect to identifying potential
vaccine candidates (Narasimhan et al., 2007a).
Two different approaches for cDNA synthesis from salivary gland mRNA were utilized in
this study. First, conventional cDNA synthesis was used to construct an antigen library
based on adult ticks. In this approach the amount of cDNA synthesized is approximately
equal to the amount of mRNA available making this strategy very laborious with respect to
the collection of starting material. This is also the primary reason why adult ticks were
used, since their salivary glands are significantly larger than those of nymphal ticks. For
synthesis of a sufficient amount of cDNA a total of 500 to 700 adult ticks were dissected. A
comparable study reported dissection of more than 1000 nymphs in order to construct an
antigen library (Schuijt et al., 2011b). The resulting cDNA was analyzed by agarose gel
electrophoresis revealing a sufficiently broad distribution of different fragments (Figure 3-8).
In this analysis a distinct band at approximately 450 bp was very prominent. A possible
explanation for this finding could be that the reverse transcriptase used for cDNA synthesis
has an optimum for synthesizing fragments of this size. This single band could still be
comprised of different fragments even though they have the same size.
Sequence analysis of random clones from this library revealed inserts encoding rRNA
among other sequences. This result reflects the unspecific reverse transcription of any
kind of RNA present in the reaction mixture, making this protocol susceptible to
contamination. It also demonstrates that, even though an mRNA extraction kit was used,
some rRNA contamination occurred diluting the diversity of the library.
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The second approach, using a SMART cDNA synthesis protocol, proved to be much more
efficient. Salivary glands of only 50 nymphs were required in order to synthesize large
amounts of cDNA. The distribution of different fragments obtained with this approach was
sufficiently broad. Furthermore, no rRNA contamination was observed, probably due to the
use of an oligo (dT) primer, which creates a second, strong selection for poly (A) tailed
RNAs. SMART cDNA synthesis has been used previously in tick salivary gland
transcriptomics (Ribeiro et al., 2006; Valenzuela, 2002; Valenzuela et al., 2002) and the
use of such cDNAs in phage display approaches also has been addressed previously
(Georgieva and Konthur, 2011). These obvious advantages, however, should not belie the
fact that there are some disadvantages of this method as well. Utilization of the two
adapter primers and subsequent PCR amplification could introduce a bias towards certain
transcripts. Additionally, the full-length transcripts need to be fragmented which was
achieved by the action of three different restriction enzymes. This step introduces a bias to
the cDNA fragments since occurrence of the restriction sites will not be completely
random. Finally the ratio of highly abundant to less abundant transcripts is unlikely to be
preserved during the PCR amplification step.
In conclusion, according to the parameters employed to evaluate the two antigen libraries,
SMART cDNA synthesis proved to be the better strategy to construct a library of desired
quality.

4.3 Screening for immunogenic peptides
Successful phage display screenings seeking to identify immunogenic proteins rely
primarily on two factors. First, the antigen library needs to be of good quality with respect
to diversity and display of antigenic peptides. Second, the availability of antibodies used to
probe the library is crucial. The low titers of anti-tick antibodies in the human blood sera
present a major limitation. The panning strategy pursued in this study has been utilized
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successfully in previous reports (Kugler et al., 2008; Meyer et al., 2012; Naseem et al.,
2010), however, convalescent sera from recently infected animals provided higher
antibody titers in those studies.
For the study presented here, two different ways of employing human blood sera were
assayed. When all sera previously classified as tick sensitized were pooled, screening with
either of the two antigen libraries constructed was unsuccessful. This could be explained
by the idea that each of the sera contains tick-specific antibodies. However, different
individuals might recognize different salivary antigens. In this case, pooling of the sera
further dilutes the tick-specific antibodies, thus impeding successful enrichment of the
corresponding antigens. None of the results obtained in the study presented here
contradict this notion. The idea that serum pooling and subsequent antibody dilution could
be a limitation is further underlined by the fact that pannings, using individual patient sera
led to identification of immunogenic salivary proteins. Another critical point of the
experimental setup is performance of the screenings as library-vs-library approaches in
which two complex mixtures are screened against each other. This double-sided high
complexity limits the number of possible specific interactions exacerbating identification of
immunogenic polypeptides.
It is noteworthy that, despite the fact whether or not a panning was judged successful, the
titers of eluted phage after each panning round increased. Thus, in all cases phage have
been enriched, however, this includes enrichment of unspecific phage particles as shown
in the respective screening ELISAs. This effect might be due to remaining serum
antibodies that recognize phage coat proteins even though the sera were pre-incubated
with Hyperphage. Presence of such antibodies also would explain the general background
signal in all screening ELISA analyses. Another explanation could be that enriched phage
particles display peptides promoting some sort of selection advantage. Factors influencing
this advantage could be an increased infectivity of the phage due to the peptide displayed,
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thereby leading to a higher production rate of a specific clone. Additionally, unspecific
binding might be caused by interactions between phage and other protein components
present in the screening setup (Vodnik et al., 2011). This last point is of special
significance when considering the very high background signals of the different sera.
Interestingly, antigens identified in this study resulted from screenings with those sera that
previously had been mentioned to reveal the best signal-to-noise ratios, confirming that
general serum stickiness is an important criterion.

4.4 Metalloprotease 1 and its homologs
Among the salivary proteins identified in this work, the metalloprotease appears to be of
greatest interest. This is primarily due to the fact that it is the only extracellular and actively
secreted protein recognized by the human immune sera.
Previous reports state that Metalloprotease 1 (MP1) of Ixodes scapularis is synthesized as
a pre-pro-enzyme containing a signal peptide as well as a pro-peptide which are both
cleaved off in order to get the active protein (Francischetti et al., 2003). MP1 has a
theoretical molecular weight of 37 kDa, a conserved zinc-binding domain as well as 12
highly conserved cysteine residues. Furthermore, it has been reported to have
fibrin(ogen)lytic activity as well as gelatinase activity (Francischetti et al., 2003). Thus, this
enzyme is hypothesized to act as an anti-hemostatic in tick saliva. Interestingly, it has
been noted that Borrelia spirochetes upregulate expression of metalloproteases in their
vertebrate hosts, potentially enhancing degradation of extracellular matrix proteins to
improve spreading of the pathogen (Gebbia et al., 2001). This fact presents one possible
route on which tick feeding can actively promote pathogen transmission, raising the
significance of the observation made in this study to suggest MP1 as a novel vaccine
candidate.
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Figure 4-1: Sequence alignment of protein sequences of the peptide displayed on the phage identified (Insert)
and the protein sequences of metalloproteases from I. scapularis (AY264367.1), I. pacificus (AY674268.1) and I.
ricinus (AM747806.1).

Increasing the potential of MP1 as an anti-tick vaccine is the finding that the protein has
close homologs in other tick species such as I. pacificus and I. ricinus. The sequence
alignment shown in Figure 4-1 demonstrates the close homology between metalloproteases
of these tick species. Additionally, the immunogenic peptide displayed on the phage in this
work, reveals high identity with all three proteins, raising hopes for a more universal, multispecies vaccine candidate (Parizi et al., 2012).
The insert identified in the phage display screening covers a sequence which coincides
exactly with the beginning of the cysteine rich region and just nine amino acids away from
the zinc-binding domain. Binding of an antibody to this region thus might interfere in
binding of the metalloprotease to proteins of the extracellular matrix, as this has been a
suggested function of the cysteine rich region (Francischetti et al., 2003). Furthermore,
binding of an antibody this close to the active site might interfere with the catalytic function
of the enzyme, for example by steric hindrance of substrate binding.
Of utmost interest for the evaluation of MP1 as a novel vaccine candidate are reports
about salivary gland metalloproteases in I. ricinus, termed Metis. (Decrem et al., 2008a;
Decrem et al., 2008b). Metis 1 is a close homolog to I. scapularis MP1 (see Figure 4-1). In
66

the studies presented by Decrem et al., the vaccination potential of Metis 1 was evaluated
and showed a negative effect on weight gaining and oviposition in ticks that fed on
vaccinated hosts. Vaccination with Metis 1 elicited an antibody response against Metis 1
and 2 in rabbits. Furthermore, knock-down of Metis 1 by RNA interference led to an
increased mortality rate in ticks (Decrem et al., 2008a; Decrem et al., 2008b). Since the
Metis proteins were analyzed because rational considerations suggested them as
immunologically interesting enzymes, the findings in this work confirmed the potential
relevance of metalloproteases in anti-tick vaccination.
This relevance is further underlined by vaccination experiments with a metalloprotease
from Haemaphysalis longicornis in rabbits even though there is little sequence identity to
metalloproteases from Ixodes species (Imamura et al., 2009).

4.5 Further binders identified
Except for the metalloprotease, all other binders identified in this work are intracellular
proteins. While it might seem appropriate to exclude non-secreted proteins as potential
immunogenic targets, host contact with these proteins is still possible and a tick ribosomal
protein has recently been suggested as a vaccine candidate (Rodriguez-Mallon et al.,
2012). Salivary glands change dynamically in gene expression and morphology during
feeding (Kaufman, 1989) with cell proliferation as well as cell death as expected outcomes.
From these cells, intracellular components can leak into the surrounding fluids and thus,
reach the host where an adaptive immune response can be initiated.
However, as determined by sequence analysis, the likelihood that all binders identified are
artifacts appears significant. This is primarily due to the fact that none of the inserts are
incorporated into the vector in the right frame. In the case of DNA ligase, ribosomal protein
and ubiquitin ligase, a high identity sequence exists in the opposite direction to the coding
sequence of the signal peptide and the gene encoding pIII. Additionally, none of the inserts
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contain a stop codon in the +3 reading frame, explaining why the respective phage could
be packaged.
In the case of α-tubulin, the orientation of the insert is correct; however the reading frame
is shifted as compared to the surrounding genetic elements of the vector. Furthermore, the
insert does not reveal a stop codon in any of the possible reading frames and the
corresponding

tubulin

sequence

has

a

100%

identity

to

human

α-tubulin. This last finding, especially, excludes α-tubulin as a significant binder.
Sequence analysis of the peptides actually displayed on the phage particles revealed two
interesting facts. First, three of the four sequences contain a cysteine residue in the Cterminal half of the peptide. Recent findings report the coupling of protein toxins to
antibodies via cysteine residues of the hinge region (M. Hust, personal correspondence)
giving room for speculations regarding the occurrence of cysteine residues in the peptides
displayed and their selection by serum antibodies.
Second, three of the four sequences show large hydrophobic stretches and only few
hydrophilic areas when analyzed in a hydrophobicity plot (data not shown). Thus, one
could speculate that the respective peptides have been selected due to unspecific
hydrophobic interactions. This also could be brought into context again with the general
stickiness of the human blood sera. Furthermore, due to the limited number of desired
immunogenic interactions (as outlined above) the possible number of unspecific
interactions is increased, leading to an enrichment of the undesired clones found in this
study.

4.6 Conclusion
The study presented here was seeking to identify salivary antigens from Ixodes scapularis
that were recognized by antibodies from human blood sera utilizing a phage display
approach. In order to perform a successful screening two main limitations had to be
68

overcome. First, the low abundance of serum antibodies specific for salivary proteins was
handled by using individual serum samples instead of serum pools. Additionally,
enrichment of anti-tick specific antibodies was successful, however, only in very small
amounts.
Second, the availability of mRNA as starting material for the construction of antigen
libraries was limiting. This issue was resolved by pursuing a SMART based cDNA
synthesis approach which includes an amplification step.
Finally, the human blood sera and antigen libraries available were successfully screened
and led to identification of a metalloprotease from I. scapularis that has close homologs in
other ixodid species as well. Previous reports about the function of this enzyme together
with vaccination trials of one homolog in I. ricinus impart high potential to this protein with
respect to acting as a novel vaccine candidate.

4.7 Outlook
The results presented in this work suggest Metalloprotease 1 from Ixodes scapularis as a
novel anti-tick vaccine candidate. However, further validation of this protein with respect to
its potential for triggering immune reactions is needed. The only validation provided so far
is based on an ELISA using human blood serum and the peptide displaying phage.
Cloning, expression and purification of the whole protein followed by ELISA analysis with
different human blood sera is required. For this examination a validated negative control
serum needs to be identified.
Furthermore, once the protein has been produced recombinantly, vaccination studies in a
suitable model organism such as a humanized mouse model can provide deeper insights
into vaccination potential of MP1.
Using the bead coupling assay presented in this work, phage display screenings could be
repeated using the enriched serum antibodies to improve antigen detection. Additionally,
69

with the optimized protocol for library construction, different tick tissues such as the midgut
as well as different time points of the feeding process could be addressed for antigen
identification. Finally, the protocols used in this study also can be utilized in analyses of
other tick species to extend our knowledge of tick-host interactions with particular focus on
humans.
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